Mild cognitive impairment: not much harm; not much help por Jeremy D. Isaacs

Ligazón do recurso

Alzheimer's disease: Have we opened the Golden Gate to disease-modifying therapy? por Jeremy D. Isaacs

Ligazón do recurso

Non-hyperammonaemic valproate encephalopathy after 20 years of treatment por Elizabeth Caruana Galizia, Jeremy D. Isaacs, Hannah R. Cock

Ligazón do recurso

PDE5 inhibitor drugs for use in dementia por Atticus H. Hainsworth, Ottavio Arancio, Fanny M. Elahi, Jeremy D. Isaacs, Feixiong Cheng

Ligazón do recurso

The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years? por Atticus H Hainsworth, Thomas P Blackburn, Elizabeth M Bradshaw, Fanny M Elahi, Philip B Gorelick, Jeremy D Isaacs, Anders Wallin, Steven CR Williams

Ligazón do recurso

Quasi-diffusion magnetic resonance imaging (QDI): A fast, high b-value diffusion imaging technique por Thomas R. Barrick, Catherine A. Spilling, Carson Ingo, Jeremy Madigan, Jeremy D. Isaacs, Philip Rich, Timothy L. Jones, Richard L. Magin, Matt G. Hall, Franklyn A. Howe

Ligazón do recurso

Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial por Mathilde M. H. Pauls, Natasha Clarke, Sarah Trippier, Shai Betteridge, Franklyn A. Howe, Usman Khan, Christina Kruuse, Jeremy B. Madigan, Barry Moynihan, Anthony C. Pereira, Debbie Rolfe, Egill Rostrup, Caroline E. Haig, Thomas R. Barrick, Jeremy D. Isaacs, Atticus H. Hainsworth

Ligazón do recurso

What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? por Anders Wallin, Suvarna Alladi, Sandra E Black, Christopher Chen, Steven M Greenberg, Deborah Gustafson, Jeremy D Isaacs, Hanna Jokinen, Raj Kalaria, Vincent Mok, Leonardo Pantoni, Florence Pasquier, Gustavo C Roman, Gary A. Rosenberg, Reinhold Schmidt, Eric E Smith, Atticus H Hainsworth

Ligazón do recurso

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease por Craig W. Ritchie, Tom C. Russ, Sube Banerjee, Bob Barber, Andrew Boaden, Nick C. Fox, Clive Holmes, Jeremy D. Isaacs, Ira Leroi, Simon Lovestone, Matt Norton, John O’Brien, Jim Pearson, Richard Perry, James Pickett, Adam D. Waldman, Wai Lup Wong, Martin N. Rossor, Alistair Burns

Ligazón do recurso

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease por Craig W. Ritchie, Tom C. Russ, Sube Banerjee, Bob Barber, Andrew Boaden, Nick C. Fox, Clive Holmes, Jeremy D. Isaacs, Ira Leroi, Simon Lovestone, Matt Norton, John O’Brien, Jim Pearson, Richard Perry, James Pickett, Adam D. Waldman, Wai Lup Wong, Martin N. Rossor, Alistair Burns

Ligazón do recurso

Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial por Mathilde MH Pauls, Jessica Fish, Lauren R Binnie, Philip Benjamin, Shai Betteridge, Brian Clarke, Mohani-Preet K Dhillon, Rita Ghatala, Fearghal AH Hainsworth, Franklyn A Howe, Usman Khan, Christina Kruuse, Jeremy B Madigan, Barry Moynihan, Bhavini Patel, Anthony C Pereira, Egill Rostrup, Anan BY Shtaya, Catherine A Spilling, Sarah Trippier, Rebecca Williams, Robin Young, Thomas R Barrick, Jeremy D Isaacs, Atticus H Hainsworth

Ligazón do recurso